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Introduction
Colicin and/or phage production was detected by plaque lysis assays, with E. coli K-12 used 174 as the sensitive strain as previously described (27) . The assay was considered as positive 175 when tested strains were surrounded by a halo, corresponding to the growth inhibition of E. 176 coli K-12 strain.
177
Fitness assays 178 Individual fitness assays 179 Fitness assay was performed as previously described in LB broth (28) by using an automatic 180 spectrophotometer (Tecan Infinite F200 Pro) that measures the OD600 in each well every 5 181 min over a period of 24 h. The experiment was repeated three times. Growth curves were then 182 analyzed and maximum growth rates was calculated and expressed in h -1 . 183 Competition experiments 184 Selected strains of our collection and constructed mutants were submitted in pairs to 185 competition in different conditions. 186 In vitro planktonic competitions 187 To determine the relative fitness of strains in planktonic conditions, they were grown in 188 couple in LB broth during 100 generations, i.e. during ten days, as previously described (29) . 189 Competitive indexes (CI) were obtained using the following formula: 190 logCFU[(isolate1/isolate2)Tx/(isolate1/isolate2)T0], isolate1 being the first strain cited and 191 isolate2 the second one in figure legends. 192 In vitro competitions in biofilm conditions 193 To determine the relative fitness of strains in biofilm conditions, they were grown at 1:1 ratio 194 in mixed colonies during seven days in aerobic and anaerobic conditions, with adaptations to 195 what's previously described (30) . For each competition, the experience was repeated three 196 times. CIs were obtained as described above. 197 Intestinal colonization mouse model Six-week-old female mice CD-1 from Charles River® (L'Arbresle, France) pre-treated with 199 streptomycin before inoculation of challenging strains were used to assess strains' relative 200 ability to colonize the mouse intestine, as previously described (28) . At least five mice were 201 used for each competition. At days 1, 4 and 7, the intestinal population of E. coli was 202 estimated by plating dilutions of weighed fresh feces on LB agar and LB agar with 203 appropriate antibiotics (kanamycin 50 mg/L or ciprofloxacin 1 mg/L). CIs were obtained as 204 described above. 205 Septicemia mouse model 206 Female mice OF1 of 14-16 g (4-week-old) from Charles River ® were used to assess the 207 strains' relative ability to cause sepsis, as previously described (31). After subcutaneous 208 inoculation of individual strain or mixed strains at a 1:1 ratio, time to death was monitored 209 during seven days. Five to ten mice were used for each assay. In all experiments, CFT073 210 strain and E. coli K-12 MG1655 strain were used as positive and negative control, 211 respectively (32). Kaplan-Meier estimates of mouse survival were performed for individual 212 strain inoculations. In competitions assays, the spleen of all spontaneously dead mice was 213 collected, weighed and pounded in physiological water and infecting population of E. coli was 214 estimated by plating dilutions of spleen suspensions on LB agar and LB agar with appropriate 215 antibiotics (kanamycin 50 mg/L, ciprofloxacin 1 mg/L or ampicillin 100 mg/L). CIs were 216 obtained as described above. 217 Urinary tract infection mouse model 218 CBA female mice of 8-22g (8-week-old) from Janvier ® (Le Genest-Saint-Isle, France) were used 219 to assess strains' relative ability to cause an ascending unobstructed urinary tract infection, as 220 previously developed in our lab (33). Ten mice were used for each competition assay, and the 221 experiments were repeated twice. CIs were obtained as described above. 
236
To visualize all data of our strain collection in one graph, a multiple correspondence analysis 237 (MCA) was realized with R software (35). The variables included in the analysis were strain 238 source, fimH allele, fluoroquinolone susceptibility, ESBL production, and biofilm formation 239 phenotype. The distance between the variables and the origin of the graph measures the 240 quality of their representation and is estimated by the square cosine (cos2): variables far from 241 the origin of the graph are discriminant and got a high cos2 and variables close to the origin 242 are not perfectly depicted and got a low cos2 ( Figure S1A ). To determine which previously established ST131 clades and subclades our 39 strains 267 belonged to, a phylogenetic tree was inferred using core genomes exempt of recombinant 268 regions ( Figure S2 ). Our collection comprised strains belonging to each subclade B (except 269 for B2 and B0) and each subclade C. Among the 19 clade B strains, 17 displayed the expected 270 fimH22, one a fimH22-like variant, and one, CES131C strain belonging to subclade B4, the 271 12 fimH30 variant that had been described as specific of clade C strains. For these reasons,
272
CES131C strain was called "Hybrid" in the rest of the study.
273
Plasmids 274 All strains but one (strain 208) harbored an IncF plasmid with a FII, FIA and FIB replicon 275 allele composition corresponding to the one previously described for clade B and C1 and C2 276 subclades strains (12), except that one C1 subclade strain (CES9C) lacked the FIB replicon as 277 described in C2 subclade strains (Table S5 ).
278
Genes encoding antibiotic resistance 279 As shown in Table S5 , our collection comprised strains that displayed a diverse antibiotic 280 resistance-encoding gene content in both clades B and C, with a gradual accumulation of 281 these genes from clade B to clade C.
282

VF-encoding genes 283
Among the genes classically sought for in ExPEC (19) , those found in our strains are 284 presented according to subclades in Table S6 . The average number of VF-encoding genes was 285 higher in clade B strains (17±2.1) than in clade C strains (14.3±1.3) (P<0.0001). The hlyF, 286 cdtB, iroN, kpsMII, cvaC, iss and ibeA genes were significantly more frequent among clade B 287 strains than among clade C strains whereas the opposite was found for the sat gene. Virotypes 288 (19) were significantly associated with subclades (P<0.00001) and virotypes not yet described 289 were displayed by Hybrid, one C1 subclade and three C2 subclade strains.
290
Individual strain phenotypic assays in vitro 291 Maximum growth rate (MGR) 292 We assessed the fitness of our 39 strains by measuring MGR in planktonic conditions ( Figure   293 3). MGR did not differ significantly between clade B and clade C strains (P = 0.08), and 294 between clinical and feces isolates (P=0.07) ( Figures 3A and 3B ). Within clade B strains, 295 those resistant to nalidixic acid seemed to have a lower MGR than the susceptible ones 296 13 ( Figure 3C ), but this difference was not significant (P=0.2). Regarding clade C strains, no 297 significant MGR differences were observed between nalidixic acid/ciprofloxacin-resistant 298 strains and susceptible strains (P=0.9) ( Figure 3D ).
299
Kinetic of early biofilm formation and expression of type 1 and curli fimbriae 300 Clade B strains were more frequently biofilm producers than clade C strains at 2 and 5 h 301 (P<0.001). We found three significantly different phenotypes of early biofilm production 302 (P<0.0001) within our 39 strains ( Figure 2 , Table S5 ): early and persistent producers (BFI≤10 303 at 2, 3 and 5 h), delayed producers (BFI>10 at 2 and 3 h but ≤10 at 5 h) and never producers 304 (BFI>10 at 2, 3 and 5 h). As BFI values after 2 and 3 h of incubation classified a given strain 305 into the same biofilm production phenotype (Figure 2A ), only BFI values obtained after 2 and 306 5 h of incubation were considered for further analyses. The 20 clade C strains were either 307 delayed producers (n=8) or never producers (n=12). There was no significant association 308 between subclades C and biofilm phenotype. Clade B strains produced biofilm more 309 frequently than clade C strains. Five (71%) of the B5 strains were early producers and two 310 (29%) were delayed producers, whereas all eight B4 strains were delayed or never producers.
311
This difference between B5 and B4 strains was statistically significant (P=0.02).
312
As the ability to form early biofilm is linked to type 1 fimbriae and curli fimbriae expression 313 (36), we studied these expressions in our strains by using the yeast agglutination test and 314 analyzing colony aspect of bacteria spotted on Congo red agar, respectively. After 2 and 5 h 315 of shaking growth, we observed that the early biofilm producers (n=8) expressed their type 1 316 fimbriae more quickly than the delayed and never producers (P≤0.0001) ( Table 1) . Applying 317 the standard yeast agglutination test as Totsika et al. (25) in which fimbriae expression is 318 assessed after ≥ 24 h, no significant differences were observed for type 1 fimbriae expression 319 according to biofilm phenotypes or clade membership, in both shaking and static conditions 320 (Table 1) . Production of curli fimbriae and cellulose was explored (Table 2) . There was a 321 14 significant association between Congo red morphotype and early biofilm formation capacity 322 (P<0.0001). Significantly more clade B (47%) than clade C strains (15%) were positive for 323 the Congo red assay (P<0.05).
324
Genes potentially linked to different phenotypes of early biofilm formation 325 To investigate the genetic factors potentially involved in differences in biofilm formation, we 326 examined the diversity in the fim operon across all strains, knowing that Fim proteins 327 participate in biofilm formation (21) and that an insertion sequence ISEc55 has been 328 described in the clade C strain fimB gene (25) that encodes a co-factor of the type 1 fimbriae 329 synthesis regulation. We found at least one non-synonymous SNP per gene in the fim operon 330 between clade B and clade C strains ( Figure S3 ). The entire fim operon was the same in all 331 clade C strains, including ISEc55 within the fimB gene. Within clade B, two strains (H1447 332 and 001-001) found as delayed biofilm producers possessed a partially deleted fim operon.
333
Hybrid, which was also a delayed biofilm producer, displayed a fim operon completely 334 different from that of the other clade B strains, showing a perfect match with the fim operon 335 of clade C strains, except for two SNPs and the absence of ISEc55 within its fimB gene 336 ( Figure S3 ). In order to assess the role of the fimB gene inactivation in clade C, we 337 constructed ∆fimB variants from an early biofilm producer B1 strain (S250 strain), and a 338 delayed biofilm producer (Hybrid). Both ∆fimB variants lost their ability to form biofilm 339 during the 5h-time period ( Figures 2B and 2C) . Complementation with the wild fimB gene 340 restored the biofilm production phenotype displayed by the parental strain of the two variants 341 ( Figures 2B and 2C) . ∆fimB variants were also submitted to yeast agglutination test and 342 Congo red assay. Both ∆fimB variants were negative for early yeast agglutination test, unlike 343 parent strains, but were positive for standard test. No changes were observed on Congo red 344 phenotype for both variants (data not shown).
345
Further genes and/or deduced proteins previously described as involved in E. coli biofilm 346 formation (21) were compared between our strains by taking S250 strain as reference (data 347 not shown). We observed identical protein sequence modifications in all B4 strains that were 348 all delayed biofilm producers: substitution K142Q in FlgD that is required for flagellar hook Strain selection for competition assays 354 In order to compare more accurately the fitness of clade B and C strains, we turned to 355 competitions assays. To select candidates for competitions among our 39 strains, we used the 356 phylogenetic history ( Figure S2 ), the multiple correspondence analysis ( Figure S1B ), acquired 357 antibiotic resistance (Table S5) and MGR values. Among clade B strains, we selected strain 358 S250 i.e. one of the two most ancestral strains (subclade B1) that we called "Ancestor".
359
Among clade C strains, we selected a C1 subclade strain, CES164C, harboring the clade C-360 characteristic fluoroquinolone resistance and a limited plasmid-mediated resistance 361 (amoxicillin resistance related to TEM enzyme), to avoid the potential burden of additional 362 resistances, such as that related to the production of CTX-M-15 in each C2 subclade strain.
363
Accordingly, we called CES164C strain "Emergent". We also retained Hybrid (subclade B4) 364 that harbors the first trait having characterized the emergence of clade C strains i.e. the 365 fimH30 allele.
366
As shown in Table 3 , Ancestor, Emergent and Hybrid displayed a similar average MGR in LB 367 (Wilcoxon Rank Test, P>0.1), were non-colicin/phage producers, but displayed differences in 368 early biofilm formation, type 1 fimbriae expression and Congo red phenotype, as well as in 369 the number and content of genes encoding antibiotic resistance and VFs (Table 3 and Figure   370 16 4). However, some VF-encoding genes were present only in Ancestor: the invasin-encoding 371 ibeA gene, the salmochelin-encoding iroBCDEN cluster, and the etsC gene encoding a 372 putative secretion system I, whereas some others were only present in Hybrid: the afaACDE 373 and draP encoding Afa/Dr adhesins, the daaF gene encoding the F1845 fimbrial adhesin, the 374 celB gene encoding a major carbohydrate active-transport system and the mcbA gene 375 encoding a bacteriocin.
376
To assess the potential role of the fimB gene in the fitness of our strains, we also retained Figure 5B ). However, a small competitive advantage was observed for both Ancestor and 393 Hybrid against Emergent, after 7 days in anaerobic biofilm conditions. Lack of the fimB gene 394 did not impact the relative fitness of Ancestor and Hybrid in these conditions ( Figure 5B ). Urinary tract infection mouse model 419 Ancestor displayed a better urinary tract colonization capacity than Emergent. In total, 30 420 mice were inoculated, with an overall infection rate of 87%, and no death was observed 48 h 421 after the inoculation. Bladders and kidneys collected 48 h after inoculation contained an 422 average of 9.10 7 CFU/g (range: 4.10 4 -2.10 9 CFU/g) and of 5.10 5 CFU/g (range: 6.10 1 -2.10 6 423 CFU/g), respectively, showing a satisfactory colonization rate of mice (data not shown). were shown to be less virulent than strains of other virotypes associated with clade C (39).
466
Regarding urinary colonization, a clade C ST131 strain compared with strains belonging to 467 well-known UPEC STs in separate mouse urinary tract infection (UTI) models, was shown to 468 have a higher UTI ability (28) . Here, we demonstrated that a representative subclade B1 strain 469 20 (Ancestor) outcompeted a representative clade C strain (Emergent) in a UTI model. 470 Moreover, the "Hybrid" B4 subclade strain (harboring the fimH30 allele) outcompeted the 471 clade C strain in the bladder but not in the kidneys. Interestingly, Hybrid strain also displayed 472 intermediate phenotypes with regard to intestine colonization and sepsis in mice, which could 473 illustrate the gradual loss of virulence of ST131 over its phylogenetic evolution.
474
As previously described, our clade B strains were more frequently early biofilm producers 475 than clade C strains (23, 24, 42) . Knocking out the fimB gene in clade B strains resulted in 476 loss of both early biofilm production capacity and early type 1 fimbriae expression. It was 477 shown that clade C ST131 mutants devoid of type 1 pili expression had a lower intestinal and 478 urinary tract colonization abilities compared to parent strains (25, 40) . We subjected ΔfimB 479 clade B mutants to competition experiments with parent strains. No differences were detected 480 neither during growth in mature biofilm conditions nor during mouse intestinal colonization 481 and septicemia model, suggesting that early biofilm production kinetic doesn't seem to 482 contribute to the better colonization abilities or to the higher virulence observed in clade B 483 strains. In the same way, E. coli biofilm formation capacity on abiotic surfaces was not 484 correlated to the ability to durably colonize mouse intestine (29). However, to confirm this 485 hypothesis, competitions between Ancestor ΔfimB mutant and Emergent would be required.
486
It may appear surprising that the successful clade C had lower virulence and lower 487 competitive ability in the intestine and in a UTI model. We propose two explanations. First, 488 the resistance to fluoroquinolones displayed by clade C may come at a direct cost (43). This 489 cost would not be revealed in maximum growth rate in planktonic conditions, but would 490 manifest as a lower colonization ability. In spite of this cost, antibiotic resistance allowed 491 clade C to spread. Second, the lower virulence may actually confer an additional evolutionary 492 advantage to clade C. According to the trade-off theory (44), host exploitation by a pathogen 493 evolves to an optimal level under a balance between the benefits in terms of transmission and 494 the costs in terms of host mortality (45). Thus, lower virulence could confer improved fitness 495 overall by avoiding symptomatic infections (46, 47) , even if it comes at the cost of lower 496 colonisation ability.
497
To conclude, we revealed substantial phenotypic differences in different clades of ST131, 498 with the successful and multi-resistant clade C being notably less able to form biofilm, and 499 less able to colonize the intestine and the urinary tract than its ancestor clade B. Whether these 
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Each strain is represented by a circle, VF encoding genes specific of a strain are indicated in 712 the unshared part of the circle, while genes in common are indicated in the intersecting region 713 between the two or three involved strains. Among the 67 genes found at least once in these 714 three strains, the 42 common genes are as follows: fdeC, fimACDEFGHI, yfcV, yagVWXYZ 715 , ykgK, chuA, fyuA, entABCEFS, fepABCDG, fes, irp2, kpsDEMMTII, K5, iss, malX, usp, 716 ompT, ompA, aslA. is expressed in log, and CI above zero means that isolate 1 outcompetes isolate 2, and 727
conversely. An interval of ±1 log was considered as the limit of discrimination. Each dot 728 represents a mouse at given times: light blue: day 1, dark blue: day 4 and green: day 7 post- Competitive index (CI) is expressed in log, and CI above zero means that isolate 1 738 outcompetes isolate 2, and conversely. An interval of ±1 log was considered as the limit of between the two or three involved strains. Among the 67 genes found at least once in these 835 three strains, the 42 common genes are as follows: fdeC, fimACDEFGHI, yfcV, yagVWXYZ 836 , ykgK, chuA, fyuA, entABCEFS, fepABCDG, fes, irp2, kpsDEMMTII, K5, iss, malX, usp, ompT, 837 ompA, aslA. expressed in log, and CI above zero means that isolate 1 outcompetes isolate 2, and conversely.
853
An interval of ±1 log was considered as the limit of discrimination. 
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Competitive index (CI) is expressed in log, and CI above zero means that isolate 1 outcompetes 867 isolate 2, and conversely. An interval of ±1 log was considered as the limit of discrimination. 
